glp-1 agonist therapy information platforms for Weight Loss and Diabetes Designing GLP-1 delivery: structural perspectives
Description
Bupropion is a norepinephrine-dopamine reuptake inhibitor that increases alertness and reduces appetite by elevating dopamine and norepinephrine in the brain's appetite-control centers
[DOI] [PubMed] [Google Scholar] 107.Abrahami D., Douros A., Yin H., Yu O.H.Y., Renoux C., Bitton A., Azoulay L
This may be related to reduced caloric intake, changes in blood sugar patterns, or direct effects on the central nervous system
Thats common, and it doesnt automatically exclude you
ArticlePubMed 26
